Drug Master Files for: formoterol fumarate
✉ Email this page to a colleague
formoterol fumarate Drug Master Files
DMF No. | Status | Type | Submission Date | Holder | Subject |
---|---|---|---|---|---|
12380 | I | II | 2/24/1997 | ASTELLAS PHARMA INC | FORMOTEROL FUMARATE |
12426 | I | II | 3/19/1997 | YAMANOUCHI IRELAND CO LTD | FORMOTEROL FUMERATE |
14154 | I | II | 5/25/1999 | INDUSTRIALE CHIMICA SRL | FORMOTEROL FUMARATE DIHYDRATE MICRONIZED |
16241 | I | II | 11/13/2002 | SICOR SWISS BRANCH | FORMOTEROL FUMARATE |
16628 | A | II | 6/3/2003 | INKE SA | FORMOTEROL FUMARATE |
19023 | A | III | 12/9/2005 | 3M DRUG DELIVERY SYSTEMS DIV | MOMETASONE & FORMOTEROL COMBINATION PRODUCT PMDI ACTUATOR |
19202 | A | II | 2/21/2006 | MYLAN LABORATORIES LTD | FORMOTEROL FUMARATE DIHYDRATE USP |
>DMF No. | >Status | >Type | >Submission Date | >Holder | >Subject |
Drug Master File Glossary
STATUS OF DMFS
- A = Active. This means that the DMF was found acceptable for filing, administratively, and is up-to-date.
- I = Inactive
- N = Not an assigned number
- P = DMF Pending Filing Review
TYPES OF DMFs
- Type I Manufacturing Site, Facilities, Operating Procedures, and Personnel (no longer applicable)
- Type II Drug Substance, Drug Substance Intermediate, and Material Used in Their Preparation, or Drug Product
- Type III Packaging Material
- Type IV Excipient, Colorant, Flavor, Essence, or Material Used in Their Preparation
- Type V FDA Accepted Reference Information